Trade RadNet Inc - RDNT CFD

About RadNet Inc.

RadNet, Inc., is a company, which is engaged in providing freestanding, fixed-site outpatient diagnostic imaging services in the United States. The Company operates through joint ventures with hospitals, approximately 331 centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Its centers provide physicians to facilitate the diagnosis and treatment of diseases and disorders. The Company’s services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. In addition, it has a software division to facilitate imaging business. The Company through its subsidiary, eRAD, Inc. sales computerized systems that distribute, display, store and retrieve digital images.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, RadNet Inc. revenues increased 23% to $1.32B. Net income before extraordinary items totaled $17M vs. loss of $14.8M. Revenues reflect Service Fee Revenue increase of 25% to $1.17B, Revenue under capitation arrangements increase of 6% to $148.3M. Net Income reflects Non-cash change in fair value of int. increase from $2.5M (expense) to $21.7M (income).

Equity composition

Common Stock $.0001 Par, 05/11, 200M auth., 37,319,725 issd. Insiders own 33.44%. IPO 7/86, 4M units (1 Common + 1 Warrant) @ $1 by RooneyPace. 11/06, Co. acq. Radiologix, Inc @ 1 share & $1.79 shr (22,442,417 shs issd.). 11/06, 1-for-2 reverse stock split. 02/07, Exchange changed from OTC Bulletin Board to NASDAQ.